These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7488557)

  • 41. Four new concepts for combatting HIV infection...and why they won't be tried anytime soon.
    PI Perspect; 1995 Dec; (no 17):1-3, 13-4. PubMed ID: 11363102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Report of the NIH Panel To Define Principles of Therapy of HIV Infection.
    Ann Intern Med; 1998 Jun; 128(12 Pt 2):1057-78. PubMed ID: 9652992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-human immunodeficiency virus drug combination strategies.
    Vandamme AM; Van Vaerenbergh K; De Clercq E
    Antivir Chem Chemother; 1998 May; 9(3):187-203. PubMed ID: 9875399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of virus load in plasma and lymph node tissue in human immunodeficiency virus infection. INCAS Study Group. Italy, Netherlands, Canada, Australia, and (United) States.
    Harris M; Patenaude P; Cooperberg P; Filipenko D; Thorne A; Raboud J; Rae S; Dailey P; Chernoff D; Todd J; Conway B; Montaner JS
    J Infect Dis; 1997 Nov; 176(5):1388-92. PubMed ID: 9359745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Viral load--significance for individualized therapy].
    Jäger H
    Med Klin (Munich); 1997 Jun; 92(6):344-6. PubMed ID: 9297066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV RNA quantitation: marker of HIV infection.
    Melroe NH; Stawarz KE; Simpson J; Henry WK
    J Assoc Nurses AIDS Care; 1997; 8(5):31-8. PubMed ID: 9298468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination antiretroviral therapy for HIV infection.
    Fischl MA
    Hosp Pract (Off Ed); 1994 Jan; 29(1):43-8. PubMed ID: 8288688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic approaches to HIV infection based on virus structure and the host pathogen interaction.
    Pauza CD; Streblow DN
    Curr Top Microbiol Immunol; 1995; 202():117-32. PubMed ID: 7587359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. INFECTIOUS DISEASE. Researchers claim to find HIV sanctuaries.
    Cohen J
    Science; 2016 Jan; 351(6272):434. PubMed ID: 26823407
    [No Abstract]   [Full Text] [Related]  

  • 50. New virologic tools for the design and analysis of clinical trials.
    Shafer RW; Merigan TC
    J Infect Dis; 1995 May; 171(5):1325-8. PubMed ID: 7751711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral dynamics of HIV: implications for drug development and therapeutic strategies.
    Havlir DV; Richman DD
    Ann Intern Med; 1996 Jun; 124(11):984-94. PubMed ID: 8624066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption.
    Lisziewicz J
    Curr Opin HIV AIDS; 2008 Mar; 3(2):104-11. PubMed ID: 19372950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Resistance to antiretroviral agents: mechanism and study methods].
    Bossi P; Calvez V; Bricaire F
    Presse Med; 1998 Dec; 27 Suppl 5():18-9. PubMed ID: 9879331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A promising search for substances, suppressing the development of the human immunodeficiency virus, among natural and semisynthetic antibiotics].
    Preobrazhenskaia MN
    Bioorg Khim; 1989 Nov; 15(11):1445-61. PubMed ID: 2696463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiviral chemotherapy for infection with human immunodeficiency virus.
    Polsky B
    Rev Infect Dis; 1989; 11 Suppl 7():S1648-63. PubMed ID: 2690300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Segmental modeling of changing viral load to assess drug resistance in HIV infection.
    Liang H
    Stat Methods Med Res; 2007 Aug; 16(4):365-73. PubMed ID: 17715162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A virologist's view from Vancouver.
    Japour A
    AIDS Clin Care; 1996 Sep; 8(9):73, 75. PubMed ID: 11363762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of antiviral agents].
    Rübsamen-Waigmann H; Pfützner A; Biesert L
    Immun Infekt; 1993 Aug; 21(4):106-10. PubMed ID: 8370592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RT-PCR for Amplification of Specific Fragments of HIV-1 Genome.
    de Béthune MP; Hertogs K
    Methods Mol Med; 2000; 24():269-82. PubMed ID: 21331915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can researchers use new drugs to push HIV envelope to extinction?
    Voelker R
    JAMA; 1996 Aug; 276(6):435-7. PubMed ID: 8691535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.